FDA: approves pembrolizumab and berahyaluronidase alfa-pmph for subcutaneous injection
Tweet Send to a Friend
(Updated - September 19, 2025 2:18 PM EDT)
FDA:On September 19 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FDA:On September 19 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
